FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2073624464> ?p ?o ?g. }

• W2073624464 endingPage "210" @default.
• W2073624464 startingPage "203" @default.
• W2073624464 abstract "Between November 1988 and May 1992, 19 patients were enrolled in a pilot study to evaluate feasibility and results of a hyperfractionated reirradiation in the treatment of head and neck recurrences or second primary tumors developed in previously irradiated volume. Patients were divided in two groups according to the initial treatment before reirradiation: group 1 included 14 patients treated with radical surgery and reirradiated because histological evidence of positive margins and/or extra capsular spread of tumor in lymph node metastases; group 2 included five patients treated with three cycles of CDDP-5FU for unresectable tumors and reirradiated because they experienced a complete or good partial (≥80%) response after chemotherapy. The reirradiation planned dose was 60 Gy in 5 weeks, with two daily fractions of 1.2 Gy spaced by 6–8 h intervals. Reirradiation was delivered exclusively with photon beams in 17 cases and with a combination of photon and electron beams in two cases. Follow-up ranged from 3 to 45 months with a median of 17 months. Of the 19 patients, 13 received the reirradiation scheduled dose of 60 Gy. For the six remaining patients, the reirradiation doses ranged from 45.6 to 57.6 Gy. All patients experienced an acute mucositis which never led to interruption of treatment. Of the 14 patients of group 1, 10 died 3–41 months after reirradiation (mean: 14 months), three were disease-free 16–37 months after reirradiation and one patient was alive with local progressive disease 39 months after the reirradiation. The overall local control within reirradiated volume was 36% before and 43% after salvage surgery. For all group 1 patients, 12- and 24-month overall survival was 64 and 36%, respectively (mean: 21 months). All patients of group 2 presented a local failure within the reirradiated volume. Three of them died 12, 16 and 25 months after reirradiation, while two of them were alive with progressive disease 25 and 30 months after reirradiation, respectively. The mean survival was 22 months. Overall, 15 late complications were noted: five grade 1, eight grade 2 and two grade 3. There was no lethal complication. Four patients alive in September 1993, and whose initial technical files were available, were enrolled in an additional study to assess the cumulative doses delivered by the two irradiations. Despite disappointing loco-regional control rates, a reirradiation of 60 Gy using a hyperfractionated schedule is feasible in terms of acute and late toxicity." @default.
• W2073624464 created "2016-06-24" @default.
• W2073624464 creator A5018267264 @default.
• W2073624464 creator A5020744257 @default.
• W2073624464 creator A5022692999 @default.
• W2073624464 creator A5044899765 @default.
• W2073624464 creator A5090078704 @default.
• W2073624464 creator A5091018870 @default.
• W2073624464 creator A5091345735 @default.
• W2073624464 date "1995-09-01" @default.
• W2073624464 modified "2023-09-23" @default.
• W2073624464 title "Hyperfractionation in the reirradiation of head and neck cancers. Result of a pilot study" @default.
• W2073624464 cites W1589768847 @default.
• W2073624464 cites W1971747664 @default.
• W2073624464 cites W1976027846 @default.
• W2073624464 cites W1978114123 @default.
• W2073624464 cites W1981373170 @default.
• W2073624464 cites W1982238941 @default.
• W2073624464 cites W1994364973 @default.
• W2073624464 cites W2001215665 @default.
• W2073624464 cites W2008739986 @default.
• W2073624464 cites W2013649479 @default.
• W2073624464 cites W2016681837 @default.
• W2073624464 cites W2016871222 @default.
• W2073624464 cites W2022820194 @default.
• W2073624464 cites W2025324987 @default.
• W2073624464 cites W2027501539 @default.
• W2073624464 cites W2029517266 @default.
• W2073624464 cites W2042579562 @default.
• W2073624464 cites W2044949380 @default.
• W2073624464 cites W2045328389 @default.
• W2073624464 cites W2052573236 @default.
• W2073624464 cites W2058015912 @default.
• W2073624464 cites W2061004798 @default.
• W2073624464 cites W2069044148 @default.
• W2073624464 cites W2073425600 @default.
• W2073624464 cites W2075735687 @default.
• W2073624464 cites W2080717274 @default.
• W2073624464 cites W2083720245 @default.
• W2073624464 cites W2094855521 @default.
• W2073624464 cites W2103094946 @default.
• W2073624464 cites W2107252466 @default.
• W2073624464 cites W2118201725 @default.
• W2073624464 cites W2124342463 @default.
• W2073624464 cites W2133555954 @default.
• W2073624464 cites W2137061992 @default.
• W2073624464 cites W2141264284 @default.
• W2073624464 cites W2146331369 @default.
• W2073624464 cites W2170414057 @default.
• W2073624464 doi "https://doi.org/10.1016/0167-8140(95)01620-v" @default.
• W2073624464 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8532907" @default.
• W2073624464 hasPublicationYear "1995" @default.
• W2073624464 type Work @default.
• W2073624464 sameAs 2073624464 @default.
• W2073624464 citedByCount "44" @default.
• W2073624464 countsByYear W20736244642012 @default.
• W2073624464 countsByYear W20736244642015 @default.
• W2073624464 countsByYear W20736244642016 @default.
• W2073624464 countsByYear W20736244642017 @default.
• W2073624464 countsByYear W20736244642018 @default.
• W2073624464 countsByYear W20736244642019 @default.
• W2073624464 countsByYear W20736244642021 @default.
• W2073624464 countsByYear W20736244642022 @default.
• W2073624464 countsByYear W20736244642023 @default.
• W2073624464 crossrefType "journal-article" @default.
• W2073624464 hasAuthorship W2073624464A5018267264 @default.
• W2073624464 hasAuthorship W2073624464A5020744257 @default.
• W2073624464 hasAuthorship W2073624464A5022692999 @default.
• W2073624464 hasAuthorship W2073624464A5044899765 @default.
• W2073624464 hasAuthorship W2073624464A5090078704 @default.
• W2073624464 hasAuthorship W2073624464A5091018870 @default.
• W2073624464 hasAuthorship W2073624464A5091345735 @default.
• W2073624464 hasConcept C141071460 @default.
• W2073624464 hasConcept C155806632 @default.
• W2073624464 hasConcept C2778496288 @default.
• W2073624464 hasConcept C2908786992 @default.
• W2073624464 hasConcept C2989005 @default.
• W2073624464 hasConcept C3018411727 @default.
• W2073624464 hasConcept C509974204 @default.
• W2073624464 hasConcept C71924100 @default.
• W2073624464 hasConceptScore W2073624464C141071460 @default.
• W2073624464 hasConceptScore W2073624464C155806632 @default.
• W2073624464 hasConceptScore W2073624464C2778496288 @default.
• W2073624464 hasConceptScore W2073624464C2908786992 @default.
• W2073624464 hasConceptScore W2073624464C2989005 @default.
• W2073624464 hasConceptScore W2073624464C3018411727 @default.
• W2073624464 hasConceptScore W2073624464C509974204 @default.
• W2073624464 hasConceptScore W2073624464C71924100 @default.
• W2073624464 hasIssue "3" @default.
• W2073624464 hasLocation W20736244641 @default.
• W2073624464 hasLocation W20736244642 @default.
• W2073624464 hasOpenAccess W2073624464 @default.
• W2073624464 hasPrimaryLocation W20736244641 @default.
• W2073624464 hasRelatedWork W1977093393 @default.
• W2073624464 hasRelatedWork W1995321234 @default.
• W2073624464 hasRelatedWork W2015000215 @default.
• W2073624464 hasRelatedWork W2019970906 @default.
• W2073624464 hasRelatedWork W2051706898 @default.

• next